Ranking results:

Past rankings:

2012
Criterium:	Position:
Overall Score:	900-1000
Networking Rank (Reputation):	> 1000
Networking Rank (Reputation):	> 1000

Ranking timeline:

Project Participation Performance(2012-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:				Projects [No]:
Year:	coordinator^*	participant^*	per partner		as coordinator	as participant
2012	0	10.050.254	1.136.581			2

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS	1
ASSOCIATION INSTITUT NECKER	1
ASSOCIATION POUR LA LUTTE CONTRE L'ALCAPTONURIE	1
CERATIUM LIMITED	1
CUDOS BV	1
MOORFIELDS EYE HOSPITAL NHS FOUNDATION TRUST	1
NARODNY USTAV REUMATICKYCH CHOROBNURCH NIRD NATIONAL INSTITUTE OF RHEUMATIC DISEASES	1
NORDIC BIOSCIENCE COMPOUND DEVELOPMENT	1
RESEARCH TOXICOLOGY CENTRE	1
ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST	1
SIFI SOCIETA INDUSTRIA FARMACEUTICA ITALIANA	1
SWEDISH ORPHAN BIOVITRUM AB	1
THE ALKAPTONURIA SOCIETY	1
THE UNIVERSITY OF LIVERPOOL	1
UNIVERSITA DEGLI STUDI DI SIENA	1
UNIVERSITE DE ROUEN	1
USTAV MOLEKULARNEJ FYZIOLOGIE A GENETIKY SLOVENSKEJ AKADEMIE VIED	1

Constancy:

Total number of partners: 17
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 17
Frequent / Rare Partner Ratio: 0

Project overview:

Start date	Project	acronym	role	funding	partners
2012-12-01	Orphan Drug for Acanthamoeba Keratitis	ODAK	participant	4.050.255	6
2012-11-01	Clinical Development of Nitisinone for Alkaptonuria	DEVELOPAKURE	participant	5.999.999	13

PSR GROUP BV - Netherlands